Masimo Corporation (MASI)
Wall Street Analysts Think Masimo (MASI) Could Surge 31.06%: Read This Before Placing a Bet
The consensus price target hints at a 31.1% upside potential for Masimo (MASI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues
MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.
Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Masimo (MASI) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Masimo Corporation (MASI) Analyst/Investor Day Transcript
Masimo Corporation (MASI) Analyst/Investor Day Transcript
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Masimo (MASI) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade
The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
3 Reasons Growth Investors Will Love Masimo (MASI)
Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.
Masimo (MASI) Upgraded to Buy: Here's What You Should Know
Masimo (MASI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
